Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared.
- 1 November 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 33 (11), 2086-2088
- https://doi.org/10.1093/clinchem/33.11.2086
Abstract
We did a comparative analysis of the physiological and analytical properties of prostate-specific antigen (PSA), acid phosphatase (ACP; EC 3.1.32) activity, and acid phosphatase antigen (PAP) in serum. The PSA assay is sensitive to 0.2 microgram/L and demonstrates good linearity (y = 1.01x + 0.74). The CV was 3.9% at 40 micrograms/L, 8.0% at 3.1 micrograms/L. PSA and PAP are less stable at 4 degrees C than at -20 degrees C. Serum PAP and ACP concentrations showed large intra-individual fluctuations (average CVs of 22% and 24%, respectively), which were not observed with PSA measurements (average CV 6.2%). We saw significant correlation with the magnitude of physiological change when analytes were compared for serially collected split samples [y(PSA) = 0.14x(PAP) + 0.00, r = 0.767], which indicates that a common factor is influencing this variation. The excellent analytical performance, tissue specificity, and small degree of intra-individual variance are characteristics that favor the measurement of PSA in serum for monitoring patients with prostatic cancer.This publication has 11 references indexed in Scilit:
- PURIFICATION OF A HUMAN PROSTATE SPECIFIC ANTIGEN1Journal of Urology, 2002
- Immunological and colorimetric determination of prostatic acid phosphatase--technical and clinical reappraisal in symptomatic patients.Clinical Chemistry, 1986
- Clinical Utility of Serum Prostatic Acid Phosphatase Measurements for Detection (Screening), Diagnosis, and Therapeutic Monitoring of Prostatic Carcinoma; Assessment of Monoclonal and Polyclonal Enzymes and Radioimmunoassays.American Journal of Clinical Pathology, 1985
- PROGNOSTIC IMPORTANCE OF PROSTATE-SPECIFIC ANTIGEN FOR MONITORING PATIENTS WITH STAGE-B2 TO STAGE-D1 PROSTATE-CANCER1985
- The Role of Serum Prostatic Acid Phosphatase as a Tumor Marker in Men with Advanced Adenocarcinoma of the ProstateJournal of Urology, 1984
- Measurement of prostate-specific antigen by radioimmunoassay.Clinical Chemistry, 1984
- Serum Prostatic Antigen Measurement in Localized Prostatic Cancer: Correlation with Clinical CourseJournal of Urology, 1982
- Stability of immunologic activity of human prostatic acid phosphatase in serum.Clinical Chemistry, 1982
- PROSTATE-SPECIFIC ACID-PHOSPHATASE - RE-EVALUATION OF RADIOIMMUNOASSAY IN DIAGNOSING PROSTATIC DISEASE1980
- Statistical estimation of the minimal detectable concentration (“sensitivity”) for radioligand assaysAnalytical Biochemistry, 1978